A subsidiary of UnitedHealth Group Inc. has acquired ChinaGate, a firm that helps drug, device and biotech companies enter the Chinese market, the companies said Wednesday.
I3, a company owned by Minnetonka-based UnitedHealth's technology arm, Ingenix, bought Shanghai-based ChinaGate for an undisclosed sum.
The companies said ChinaGate has extensive experience with the State Food and Drug Administration, China's version of the U.S. Food and Drug Administration, and has helped bring more than 450 medical and consumer health products into the Chinese market.
ChinaGate has also helped clients sell Chinese-made products globally.
CHEN MAY YEE
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
US probes whether Tesla Autopilot recall did enough to make sure drivers pay attention
The U.S. government's auto safety agency is investigating whether last year's recall of Tesla's Autopilot driving system did enough to make sure drivers pay attention to the road.
Business
Fed's preferred inflation gauge shows price pressures stayed elevated last month
A measure of inflation closely tracked by the Federal Reserve remained uncomfortably high in March, likely reinforcing the Fed's reluctance to cut interest rates anytime soon and underscoring a burden for President Joe Biden's re-election bid.
Business
After an ATF ruling, the bottom falls out for a St. Cloud firearms manufacturer
Maxim Defense Industries business is anchored in pistol braces, which federal regulators say often turn handguns into tightly controlled short-barreled rifles
Business
Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a month
Alphabet and Microsoft are leading the U.S. stock market on Friday toward the finish of its first winning week in the last four.
Business
Rooting for Trump to fail has made his stock shorters millions
Rooting for Donald Trump to fail has rarely been this profitable.